Form 4: Analog Devices CEO Vincent Roche Exercises Options and Sells Shares
SEC Form 4 Filing
Analog Devices CEO Vincent Roche exercised stock options and sold shares on January 2, 2025, according to a Form 4 filing with the SEC.
Summary
- On January 2, 2025, Vincent Roche, Chair & CEO of Analog Devices Inc., exercised non-qualified stock options to acquire 10,000 shares of common stock at a price of $91.13 per share.
- Simultaneously, Roche sold 10,000 shares of Analog Devices common stock at a price of $215.49 per share.
- Following these transactions, Roche directly owns 21,982.973 shares and indirectly owns 34,828 shares through the Vincent Roche 2023 Grantor Retained Annuity Trust and 43,515 shares through the Vincent Roche 2024 Grantor Retained Annuity Trust.
- The sale was conducted pursuant to a pre-arranged 10b5-1 trading plan adopted on March 1, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Executive stock transactions are common and closely watched by investors for insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on insider information.
Comparison to Industry Standards
- Executive compensation practices, including stock options and sales, are common across the semiconductor industry.
- Companies like Texas Instruments (TXN) and Qualcomm (QCOM) also utilize stock-based compensation and have executives who regularly file Form 4s.
- The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| 03/29/2019 | Date the Non-Qualified Stock Option became exercisable |
| 03/01/2024 | Date of adoption of the 10b5-1 plan |
| 08/25/2023 | Date of the Vincent Roche 2023 Grantor Retained Annuity Trust |
| 10/03/2024 | Date of the Vincent Roche 2024 Grantor Retained Annuity Trust |
| 01/02/2025 | Date of transaction (option exercise and share sale) |
| 01/03/2025 | Date of signature of the Form 4 filing |
| 03/29/2028 | Expiration date of the Non-Qualified Stock Option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.